title: Proanthocyanidin Attenuation of Oxidative Stress and NF- κ B Protects Apolipoprotein E-Deficient Mice against Diabetic Nephropathy.
abstract: Hyperlipidemia and hyperglycemia result in oxidative stress and play a major role in the development of diabetic nephropathy (DN). We explored the effects of proanthocyanidin (PA) on the induction and progression of DN in apolipoprotein E-deficient mice. Diabetes Mellitus was induced in ten-week-old male apoE(-/-)mice using streptozotocin (STZ). Mice were fed with a high-fat diet in presence or absence of PA. PA treatment significantly reduced the high cholesterol levels, restored renal functions, and reduced albuminuria in the PA-treated diabetic mice compared with the diabetic untreated mice. In addition, the glomerular mesangial expansion in the diabetic mice was attenuated as a result of PA supplementation. Moreover, PA treatment restored the elevated levels of MDA and CML and the reduced activity of SOD and GSH in the diabetic mice. Furthermore, PA feeding reduced the activation and translocation of NF- κ B to the nucleus compared with the diabetic untreated animals. Reduction of NF- κ B activation resulted in the attenuation of the expression of IL-6, TGF β , and RAGE which protected PA-treated mice against DN. The renoprotective effects of PA were found to be time independent regardless of whether the dietary feeding with PA was started pre-, co-, or post-STZ injection. In conclusion, part of the beneficial effects of PA includes the disruption of the detrimental AGE-RAGE-NF κ B pathways.
authors.affiliation: Department of Biochemistry, Faculty of Science, King Abdulaziz University, P.O. Box 80203, Jeddah 21589, Saudi Arabia.
authors.forename: Abdulrahman L
authors.initials: AL
authors.lastname: Al-Malki
authors.forename: Ahmed Amir Radwan
authors.initials: AA
authors.lastname: Sayed
authors.forename: Haddad A
authors.initials: HA
authors.lastname: El Rabey
references.citation: Evid Based Complement Alternat Med. 2013;2013:983923
references.pmid: 23365614
references.citation: J Nutr. 2009 Nov;139(11):2072-8
references.pmid: 19759248
references.citation: Diabetes. 2002 Dec;51(12):3532-44
references.pmid: 12453911
references.citation: Arch Pharm Res. 2012 Jan;35(1):69-76
references.pmid: 22297744
references.citation: Diabetes. 1999 Jan;48(1):1-9
references.pmid: 9892215
references.citation: J Clin Invest. 1998 Mar 1;101(5):1142-7
references.pmid: 9486985
references.citation: Biofactors. 1999;10(2-3):169-74
references.pmid: 10609878
references.citation: Biol Pharm Bull. 2004 Sep;27(9):1459-61
references.pmid: 15340239
references.citation: Eur Rev Med Pharmacol Sci. 2012 Jun;16(6):808-15
references.pmid: 22913214
references.citation: Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10771-8
references.pmid: 7971961
references.citation: J Sci Food Agric. 2010 Jan 30;90(2):349-56
references.pmid: 20355053
references.citation: J Lab Clin Med. 1996 Dec;128(6):568-78
references.pmid: 8960640
references.citation: Eur J Clin Invest. 2013 Jan;43(1):56-63
references.pmid: 23190272
references.citation: Curr Diab Rep. 2006 Dec;6(6):455-62
references.pmid: 17118229
references.citation: J Cell Physiol. 2010 Mar;222(3):669-75
references.pmid: 19950211
references.citation: Diabetes. 2009 Nov;58(11):2450-6
references.pmid: 19675139
references.citation: Lab Invest. 2002 Aug;82(8):999-1006
references.pmid: 12177238
references.citation: Biochimie. 2008 Mar;90(3):450-9
references.pmid: 18157951
references.citation: Gen Pharmacol. 1998 May;30(5):771-6
references.pmid: 9559333
references.citation: J Pharm Pharmacol. 2011 Mar;63(3):423-8
references.pmid: 21749391
references.citation: J Am Soc Nephrol. 2002 Jan;13(1):108-116
references.pmid: 11752027
references.citation: J Clin Pharm Ther. 1998 Oct;23(5):385-9
references.pmid: 9875688
references.citation: J Med Chem. 2012 May 10;55(9):4169-77
references.pmid: 22509764
references.citation: Diabetologia. 1982 Mar;22(3):194-8
references.pmid: 6210590
references.citation: Evid Based Complement Alternat Med. 2012;2012:140103
references.pmid: 21837246
references.citation: Prog Lipid Res. 1997 Mar;36(1):1-21
references.pmid: 9373618
references.citation: Biochem Biophys Res Commun. 1972 Jan 31;46(2):849-54
references.pmid: 4400444
references.citation: Cell Biochem Funct. 2008 Apr;26(3):374-80
references.pmid: 18210382
references.citation: J Physiol Biochem. 2012 Jun;68(2):263-9
references.pmid: 22237966
references.citation: Diabetologia. 1998 Jul;41(7):784-90
references.pmid: 9686919
references.citation: Phytother Res. 2009 Dec;23(12):1738-41
references.pmid: 19358210
references.citation: Anal Biochem. 1979 Jun;95(2):351-8
references.pmid: 36810
references.citation: Evid Based Complement Alternat Med. 2012;2012:580104
references.pmid: 22991571
references.citation: Horm Metab Res. 2008 Nov;40(11):752-9
references.pmid: 18711692
references.citation: Diabetes. 2005 Jun;54(6):1615-25
references.pmid: 15919781
references.citation: Free Radic Res. 2002 Feb;36(2):189-93
references.pmid: 11999387
references.citation: Am J Clin Nutr. 1998 Jan;67(1):50-7
references.pmid: 9440375
references.citation: Biochim Biophys Acta. 1979 Jan 4;582(1):67-78
references.pmid: 760819